These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25715778)

  • 21. Anti-tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells.
    Igase M; Shousu K; Fujiki N; Sakurai M; Bonkobara M; Hwang CC; Coffey M; Noguchi S; Nemoto Y; Mizuno T
    Vet Comp Oncol; 2019 Jun; 17(2):184-193. PubMed ID: 30761736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serum ferritin as a tumor marker for canine histiocytic sarcoma.
    Friedrichs KR; Thomas C; Plier M; Andrews GA; Chavey PS; Young KM
    J Vet Intern Med; 2010; 24(4):904-11. PubMed ID: 20561186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma.
    Hirabayashi M; Chambers JK; Kishimoto TE; Nguyen SV; Ishikawa Y; Rimpo K; Nakayama H; Uchida K
    Vet Comp Oncol; 2022 Jun; 20(2):465-475. PubMed ID: 34907644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
    Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
    Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
    Skorupski KA; Rodriguez CO; Krick EL; Clifford CA; Ward R; Kent MS
    Vet Comp Oncol; 2009 Jun; 7(2):139-44. PubMed ID: 19453368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma.
    Laursen MB; Falgreen S; Bødker JS; Schmitz A; Kjeldsen MK; Sørensen S; Madsen J; El-Galaly TC; Bøgsted M; Dybkær K; Johnsen HE;
    Exp Hematol; 2014 Nov; 42(11):927-38. PubMed ID: 25072621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
    Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
    Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line.
    Chen W; Liu I; Tomiyasu H; Lee J; Cheng C; Liao AT; Liu B; Liu C; Lin C
    Vet J; 2019 Dec; 254():105398. PubMed ID: 31836165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.
    Li WW; Takahashi N; Jhanwar S; Cordon-Cardo C; Elisseyeff Y; Jimeno J; Faircloth G; Bertino JR
    Clin Cancer Res; 2001 Sep; 7(9):2908-11. PubMed ID: 11555609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease.
    Uchida M; Matsumiya Y; Tsuboi M; Uchida K; Nakagawa T; Fujii W; Kobayashi T; Tsujimoto H; Ohmi A; Tomiyasu H; Motegi T; Maeda S; Momoi Y; Yonezawa T
    Vet Comp Oncol; 2023 Sep; 21(3):391-400. PubMed ID: 37088561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an Orthotopic Intrasplenic Xenograft Mouse Model of Canine Histiocytic Sarcoma and Its Use in Evaluating the Efficacy of Treatment with Dasatinib.
    Takada M; Smyth LA; Hix JM; Corner SM; Kiupel M; Yuzbasiyan-Gurkan V
    Comp Med; 2019 Feb; 69(1):22-28. PubMed ID: 30717820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical prognostic factors in canine histiocytic sarcoma.
    Dervisis NG; Kiupel M; Qin Q; Cesario L
    Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
    Keshelava N; Seeger RC; Groshen S; Reynolds CP
    Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine histiocytic sarcoma cell lines with SHP2 p.Glu76Gln or p.Glu76Ala mutations are sensitive to allosteric SHP2 inhibitor SHP099.
    Tani H; Kurita S; Miyamoto R; Ochiai K; Tamura K; Bonkobara M
    Vet Comp Oncol; 2020 Jun; 18(2):161-168. PubMed ID: 31339650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.
    Thaiwong T; Sirivisoot S; Takada M; Yuzbasiyan-Gurkan V; Kiupel M
    Vet Comp Oncol; 2018 Jun; 16(2):220-228. PubMed ID: 28929581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma.
    Prouteau A; Denis JA; De Fornel P; Cadieu E; Derrien T; Kergal C; Botherel N; Ulvé R; Rault M; Bouzidi A; François R; Dorso L; Lespagnol A; Devauchelle P; Abadie J; André C; Hédan B
    Sci Rep; 2021 Jan; 11(1):877. PubMed ID: 33441840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcoma.
    Asada H; Ichii O; Tomiyasu H; Uchida K; Chambers JK; Goto-Koshino Y; Ohno K; Kon Y; Tsujimoto H
    J Vet Med Sci; 2019 Mar; 81(3):353-356. PubMed ID: 30662044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
    Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
    Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases expression in spontaneous canine histiocytic sarcomas and its xenograft model.
    Fayyad A; Lapp S; Risha E; Pfankuche VM; Rohn K; Barthel Y; Schaudien D; Baumgärtner W; Puff C
    Vet Immunol Immunopathol; 2018 Apr; 198():54-64. PubMed ID: 29571518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.